Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 64980-645

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 64980-645). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5387e98-figure-01 (B5387e98 Figure 01)

Chemical structure of Ipratropium Bromide, showing its molecular arrangement including functional groups and sulfate components as part of the compound.*

FDA Label Image

B5387e98-figure-02 (B5387e98 Figure 02)

Chemical structure of Ipratropium Bromide depicted as a molecular diagram showing its atomic arrangement and functional groups.*

FDA Label Image

B5387e98-figure-03 (B5387e98 Figure 03)

A line graph depicting lung function over time after dosing with Albuterol, Ipratropium, and a combination of Ipratropium Bromide and Albuterol Sulfate inhalation. The x-axis represents hours after dosing, and the y-axis shows volume in liters, illustrating differences in respiratory response among the treatments across a 7-hour period.*

FDA Label Image

B5387e98-figure-04 (B5387e98 Figure 04)

A data table titled 'Adverse events occurring in more than 1% of more than 1 treatment group(s) and where the combination treatment showed the highest percentage.' It presents body system-specific adverse events and their frequencies (%) in patient groups treated with Albuterol, Ipratropium, and the combination Ipratropium Bromide and Albuterol Sulfate. The table lists patient counts and adverse event percentages for categories including body as a whole, digestive, musculo-skeletal, respiratory, and urogenital systems.*

FDA Label Image

Carton-30ct-label (Carton 30ct Label)

Carton packaging label for Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg inhalation solution, USP, by Rising Pharma Holdings, Inc. The label indicates a solution dosage form for oral inhalation only, containing 30 x 3 mL sterile unit-dose vials. The label includes product NDC 64980-645-03, storage and usage instructions, and a barcode.*

FDA Label Image

Carton-60ct-label (Carton 60ct Label)

Packaging label for Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, USP by Rising Pharma Holdings, Inc. The label indicates a solution dosage form for oral inhalation only, with packaging containing twelve sterile unit-dose vials of 3 mL each. The NDC is 64980-645-06.*

FDA Label Image

Figure-1 (Figure 1)

An instructional illustration showing how to use a respiratory inhalation solution device. It depicts a person assembling or preparing a nebulizer mouthpiece and medication vial, indicating the step before inhalation treatment for Ipratropium Bromide and Albuterol Sulfate solution.*

FDA Label Image

Figure-2 (Figure 2)

An instructional diagram showing a respiratory inhaler with an attached mouthpiece on the left and a hand inserting or removing a small cylindrical component on the right, illustrating part of the inhaler assembly or use process.*

FDA Label Image

Figure-3 (Figure 3)

Instructional illustration showing a person using a respiratory inhalation device by placing the mouthpiece in the mouth to inhale the medication. The image depicts proper inhaler usage technique for delivering the solution.*

FDA Label Image

Figure-4 (Figure 4)

An instructional line drawing showing a person using a nebulizer with a face mask for inhalation. The image focuses on how the mask fits over the nose and mouth to deliver the aerosolized medication from the nebulizer device.*

FDA Label Image

Vial Label (Vial Label)

Drug facts and usage instructions for Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg inhalation solution, USP in 5 x 3 mL unit-dose vials. Includes active and inactive ingredients, storage conditions, and dosing guidance. Distributed by Rising Pharma Holdings, Inc., with contact information and lot/expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.